this practical for routine applications in the clinical laboratory by increasing the number of samples that can be run at one time and shortening the centrifuge time from 18 to less than 2 h. The separations and reproducibility compare favorably with those obtained with a swinging-bucket rotor. 
Materials and Methods

Apparatus
The ultracentrifuge, rotor, and accessories were purchased from Du Pont Instruments, in relative centrifugal force. At 65 000 rpm within the tube, the miniinuni rcf is 339 500 and the maximum is 400 000. Because the contents of the tube must reorient, both while accelerating and decelerating, it is necessary that a centrifuge be fitted with attachments for controlled starting and slow stopping to achieve good resolution. The rotor is used in an OTD 65 centrifuge with a Sorvall Automatic Rate Con- 
Procedure
The tissue cytosols are prepared as described by Horwitz et al. (3). Frozen mammary carcinoma tissue from patients is pulverized and homogenized in three volumes of 5 mmol/ liter sodium phosphate buffer, pH 7.4, containing, per liter, 1 mmol of EDTA, 1 mmol of monothioglycerol, and 100 ml of glycerol. The chilled homogenate is centrifuged in the cold for 45 mm at 45000 X g (Du Pont-Sorvall RC-2B.) A small portion of the cytosol supernate is analyzed for protein by the Commassie Blue dye (4) method.1
When analyzing for both receptors, 250 l of cytosol is placed in each of four tubes. Five hundred picomoles of R5020, a synthetic progestin (6), is added to tube two and 100 pmol of estradiol to tube four. After a 15-mm incubation, 5 pmol of [3H1R50202 is added to tubes one and two and 1 pmol of London, England) in21 hat 169 000 X g. Four-drop fractions were collected.
The first peak is the 8 S fraction
[3H]estradiol (New England Nuclear) to tubes three and four.
All tubes are incubated for at least 1.5 h at 4#{176}C. [l'tC]Albumin may be added to one tube as a marker. The incubation solution is then added to a charcoal pellet, vortex-mixed, and incubated in the cold for 15 min, to remove any unbound steroid before centrifuging in the cold at 1700 X g for 10 mm. Of the supernatant fluid, 200 il is layered on top of 4 ml of a 5-20% sucrose gradient prepared in the phosphate buffer described above. Sucrose gradients can be prepared 2 h to nine days before use, in 5-mi tubes with a gradient mixer (7) (Buchler Instruments, Inc., Fort Lee, N.J. 07025) and stored in the refrigerator.
Mineral oil, 200 l, is layered on top of the sample. Figure 2A shows a typical separation of the 45 and 8S components ofprogesterone binding after centrifuging for 1.5 h at 365 000 x g. [3H]R5020 is added to the cytosol in the presence and absence of excess cold R5020. Figure 2B The separations obtained are reproducible. Figure 3 shows the separation obtained on the same tissue cytosol containing [3H]R5020 on three different days, under the same conditions as described above. Although the activity declined by more than half in the first day, the peak remained in the same fractions. This lack of stability for progesterone receptors has been reported by others (9). A similar experiment looking at [3H]estradiol binding on different days also shows reproducible peaks, but no loss of binding during four days.
Results and Discussion
We have been using the vertical rotor for a year to identify progesterone receptors and confirm estrogen receptor values that are questionable by the Scatchard plot analysis of the dextran-coated charcoal method (10). We have experienced little down time. Because of the short centrifugation time, several tissues can be completely processed in one day, adding greatly to the practibility of the density gradient technique as a routine clinical assay.
methyl-1-propanol, widely used in clinical measurement of alkaline phosphatase activity, contains an impurity that inhibits the activity of the enzyme. Analysis of several lots of 2-amino-2-methyl-1-propanol has demonstrated the presence of a material, the concentration of which correlates well with alkaline phosphatase activity. Mass spectral analysis of this material indicates that it is a substituted ethylenediamine compound. Zinc chelation is discussed as a possible mode of its inhibition. Further work is in progress to separate and characterize this and other compounds in the buffer and to determine their modes and degrees of alkaline phosphatase inhibition.
Alkaline phosphatase (EC 3.1.3.1) activity is commonly measured from the rate of formation of p-nitrophenol from p-nitrophenylphosphate (1, 2). The rate is enhanced, for convenience and increased sensitivity, by use of an alkaline buffering compound, which is transphosphorylated in the reaction. The compound 2-amino-2-methyl-1-propanol is widely used for this purpose (2,3) and is the buffer used for alkaline phosphatase determination with the DuPont Automatic Clinical Analyzer (aca).
Buffer used on the aca has required careful screening at Du Pont, so as to reject certain lots that result in lower-thanexpected alkaline phosphatase activity. Recent lots of 2-amino-2-methyl-1-propanol have shown this problem more frequently and severely. We continue to reject those lots giving low activity. Here we report preliminary results of work to characterize 2-amino-2-methyl-1-propanol impurities and wish to call attention to an organic impurity, the concentration of which correlates well with depression of alkaline phosphatase activity. X-ray fluorescence studies were done with an Exam I energy dispersive spectrometer (Edax International, Inc., Prairie View, 111.60069).
Material and Methods
Apparatus
Atomic absorption measurements were done with a Model 503 AA spectrophotometer (Perkin-Elmer Corp., Norwalk, Conn. 06856).
For gas chromatography we used a Model 5840A gas chromatograph (Hewlett Packard, Avondale Division, Avondale, Pa. 19311).
Columns for GCIMS work were packed with Carbowax 20M on Carbopack B. Those for GC work were packed with "Tenax GC" in glass columns.
